CA Stock MarketDetailed Quotes
GUD Knight Therapeutics Inc
- 5.300
- +0.090+1.73%
15min DelayMarket Closed Nov 21 16:00 ET
534.25MMarket Cap-18275P/E (TTM)
5.300High5.200Low97.32KVolume5.200Open5.210Pre Close511.52KTurnover6.23052wk High0.11%Turnover Ratio100.80MShares5.07052wk Low-0.29EPS TTM455.97MFloat Cap11.030Historical HighLossP/E (Static)86.03MShs Float3.510Historical Low-0.16EPS LYR1.92%Amplitude--Dividend TTM0.69P/B1Lot Size--Div YieldTTM
Knight Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -66.93%5.02M | 26.92%-1.09M | 615.50%30.88M | -20.14%35.94M | 170.31%17.94M | 28.61%15.17M | -111.22%-1.49M | -66.49%4.32M | 0.86%45M | 41.81%6.64M |
| Net income from continuing operations | -99.11%85K | -205.54%-1.94M | -15.47%-4.55M | 43.68%-16.84M | -60.17%-24.33M | 502.64%9.59M | -26.87%1.84M | 79.07%-3.94M | -290.70%-29.89M | -82.97%-15.19M |
| Operating gains losses | 250.18%2.92M | 27.15%-3.46M | 32.74%14.06M | 44.52%17.63M | 239.10%13.73M | 26.90%-1.94M | -377.50%-4.75M | -53.97%10.59M | 175.94%12.2M | -691.61%-9.87M |
| Depreciation and amortization | -2.26%13.39M | 8.32%13.17M | -3.84%12.58M | -19.52%50.4M | -43.26%11.46M | -10.28%13.7M | -11.76%12.16M | -2.23%13.08M | 30.69%62.62M | 6.28%20.19M |
| Asset impairment expenditure | ---- | ---- | ---- | -61.39%9.26M | ---- | ---- | ---- | ---- | 4,735.48%23.98M | 4,316.13%21.9M |
| Remuneration paid in stock | 129.51%801K | 26.93%1.05M | -34.87%510K | 23.25%2.33M | -7.32%367K | 27.37%349K | -0.60%828K | 103.38%783K | -38.00%1.89M | 45.05%396K |
| Deferred tax | 25.69%-1.34M | 184.89%1.41M | -36.98%-4.27M | 46.71%-9.13M | 71.14%-2.55M | 7.30%-1.8M | 37.98%-1.66M | 15.22%-3.12M | -124.27%-17.13M | -153.63%-8.83M |
| Other non cashItems | -93.87%154K | -50.24%617K | -261.87%-2.97M | 421.47%10.3M | 195.27%4.72M | 981.05%2.51M | 11.61%1.24M | 283.47%1.83M | -673.17%-3.2M | -2,505.26%-4.95M |
| Change In working capital | -51.93%-10.99M | -7.08%-11.93M | 203.91%15.51M | -412.12%-28.01M | 77.58%5.29M | -185.52%-7.24M | -177.05%-11.14M | -688.43%-14.93M | -972.41%-5.47M | 162.26%2.98M |
| -Change in receivables | -153.52%-9.19M | -49.44%998K | 110.90%1.28M | 118.61%5.58M | 82.22%-1.81M | 1,126.36%17.17M | 115.02%1.97M | -45.89%-11.76M | -449.28%-29.96M | -180.65%-10.16M |
| -Change in inventory | 25.59%-9.64M | -172.66%-5.66M | 259.63%4.19M | 106.11%698K | 294.55%18.35M | -227.50%-12.96M | -303.53%-2.07M | -378.47%-2.63M | 33.51%-11.43M | -469.38%-9.43M |
| -Change in prepaid assets | -226.70%-3.41M | 3,077.59%1.73M | -114.20%-461K | -1,532.99%-6.43M | -22,471.05%-8.58M | -24.11%-1.05M | -104.16%-58K | 457.10%3.25M | -111.05%-394K | -101.78%-38K |
| -Change in payables and accrued expense | 284.84%11.27M | 46.81%-9.58M | 260.10%9.83M | -162.23%-22.79M | -105.82%-1.41M | -986.63%-6.1M | -327.08%-18.02M | -46.23%2.73M | 696.24%36.63M | 207.95%24.18M |
| -Change in other current liabilities | 99.63%-16K | -91.73%582K | 110.26%668K | -1,495.90%-5.06M | 18.96%-1.27M | -402.25%-4.31M | 671.87%7.03M | -714.34%-6.51M | -129.54%-317K | -569.25%-1.57M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -66.93%5.02M | 26.92%-1.09M | 615.50%30.88M | -20.14%35.94M | 170.31%17.94M | 28.61%15.17M | -111.22%-1.49M | -66.49%4.32M | 0.86%45M | 41.81%6.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -67.76%11.53M | 179.83%11.75M | -179.62%-24.37M | 146.51%29.34M | 97.08%-1.9M | 1,184.83%35.76M | 126.96%4.2M | -141.86%-8.71M | 40.08%-63.08M | -786.70%-65.02M |
| Net PPE purchase and sale | -64.76%-374K | -333.54%-685K | -585.48%-850K | 133.76%974K | 166.03%1.48M | 59.68%-227K | -586.96%-158K | -133.96%-124K | 24.71%-2.89M | 17.24%-2.25M |
| Net intangibles purchas and sale | -2,685.00%-1.67M | ---16.74M | -31.50%-10.08M | 60.72%-9.01M | 70.93%-1.28M | 18.92%-60K | --0 | -3,176.50%-7.67M | 89.59%-22.93M | -2,780.39%-4.41M |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.35M | ---- | ---- |
| Net investment purchase and sale | -52.59%13.57M | 3,020.22%29.17M | -331.56%-14.11M | 139.33%13.74M | 76.69%-12.97M | 1,176.57%28.63M | -137.53%-999K | -115.80%-3.27M | -130.05%-34.93M | -558.01%-55.63M |
| Dividends received (cash flow from investment activities) | ---- | ---- | --581K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | --97K | 1,112.72%23.64M | 496.32%10.86M | --7.42M | --5.36M | ---- | -186.96%-2.33M | -1,542.63%-2.74M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -67.76%11.53M | 179.83%11.75M | -179.62%-24.37M | 146.51%29.34M | 97.08%-1.9M | 1,184.83%35.76M | 126.96%4.2M | -141.86%-8.71M | 40.08%-63.08M | -786.70%-65.02M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 65.06%-3.93M | 48.58%-11.36M | 75.60%-2.9M | -2,838.05%-81M | -227.62%-35.7M | -101.09%-11.24M | -23.21%-22.1M | -74.28%-11.87M | 96.48%-2.76M | 222.22%27.97M |
| Net issuance payments of debt | -117.08%-1.4M | -61.34%-7.17M | -144.50%-2.07M | -157.24%-18.02M | -131.47%-12.09M | 5.43%-644K | 26.40%-4.44M | -277.23%-845K | 321.89%31.49M | 7,083.18%38.43M |
| Net common stock issuance | 74.84%-2.47M | 91.10%-1.24M | --0 | -77.85%-53.48M | -119.75%-19.08M | -120.32%-9.83M | -35.99%-13.95M | -57.80%-10.51M | 53.32%-30.07M | 63.06%-8.68M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 409.09%448K | 223.81%340K | -19.57%74K | 11.76%380K | -15.18%95K | 35.38%88K | 19.32%105K | 22.67%92K | 14.48%340K | 28.74%112K |
| Interest paid (cash flow from financing activities) | 40.82%-503K | 13.47%-3.3M | -49.59%-905K | -118.61%-9.88M | -144.75%-4.62M | -66.67%-850K | -120.37%-3.81M | ---605K | ---4.52M | ---1.89M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 65.06%-3.93M | 48.58%-11.36M | 75.60%-2.9M | -2,838.05%-81M | -227.62%-35.7M | -101.09%-11.24M | -23.21%-22.1M | -74.28%-11.87M | 96.48%-2.76M | 222.22%27.97M |
| Net cash flow | ||||||||||
| Beginning cash position | 60.68%60.81M | 11.77%62.84M | -18.02%58.76M | -16.62%71.68M | -23.97%77.42M | -59.36%37.84M | -50.45%56.22M | -16.62%71.68M | -62.56%85.96M | 10.09%101.82M |
| Current changes in cash | -68.21%12.62M | 96.41%-695K | 122.24%3.62M | 24.54%-15.72M | 35.37%-19.66M | 1,265.08%39.68M | 4.34%-19.38M | -160.52%-16.27M | 85.01%-20.84M | -248.15%-30.41M |
| Effect of exchange rate changes | 404.59%332K | -232.37%-1.33M | -43.63%456K | -57.20%2.8M | 268.63%999K | -101.88%-109K | 1,407.79%1.01M | 32.84%809K | 240.66%6.55M | -87.73%271K |
| End cash Position | -4.73%73.76M | 60.68%60.81M | 11.77%62.84M | -18.02%58.76M | -18.02%58.76M | -23.97%77.42M | -59.36%37.84M | -50.45%56.22M | -16.62%71.68M | -16.62%71.68M |
| Free cash from | -80.03%2.97M | -1,025.85%-18.51M | 672.40%19.89M | 35.43%25.98M | 108,240.00%16.22M | 33.38%14.88M | 67.05%-1.64M | -127.60%-3.48M | 110.68%19.18M | -100.83%-15K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data